XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
  Memory
  Regeneration
  Stroke
  Brain Diseases
  Headache
  Spinal Cord Diseases
  Demyelinating Diseases
  Neurodegenerative Diseases
  Taste
  Trigeminal Neuralgia
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Stroke Channel
subscribe to Stroke newsletter

Latest Research : Neurosciences : Stroke

   DISCUSS   |   EMAIL   |   PRINT
Triple Therapy of Aspirin, ACE Inhibitors and Statins Also Reduces Severity of Stroke
May 7, 2006, 19:58, Reviewed by: Dr. Sanjukta Acharya

�It�s possible that these three drugs work synergistically to reduce the amount of brain tissue that is damaged in the penumbra by improving blood flow�

 
Taking the �triple therapy� of aspirin, cholesterol drugs, and blood pressure drugs to prevent stroke also reduces stroke severity if one occurs, according to a new study published in the April 25, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

People who were taking all three drugs had less severe strokes, had shorter hospital stays, and were better able to function when leaving the hospital than those who were taking one, two, or none of the three drugs.

The study examined 179 people who came to the hospital within 24 hours after having a stroke. Researchers looked at how severe the strokes were, how much brain cell damage was caused by the stroke, and other factors. The participants were divided into five groups: 69 people were taking none of the three drugs; 47 people were taking aspirin only; 29 were taking aspirin and ACE inhibitors, or blood pressure drugs; 14 were taking aspirin and statins, or cholesterol-lowering drugs; and 20 people were taking all three drugs.

The study also found that even though the amount of initial brain cell damage was roughly equal, on average, among the five groups, the amount of brain cells that were still at risk of damage at the time of hospital admission was smaller among those taking all three drugs.

Lack of normal blood flow to brain cells sets off a chain reaction. Brain cells in a progressively larger area are endangered as blood flow is reduced. Quick medical treatment is the best chance to save this region of brain cells, called the penumbra.

�It�s possible that these three drugs work synergistically to reduce the amount of brain tissue that is damaged in the penumbra by improving blood flow,� said study author and neurologist Magdy Selim, MD, PhD, of Harvard Medical School and Co-Director of the Stroke Center of Beth Israel Deaconess Medical Center in Boston, MA. �These results need to be confirmed before this triple therapy would be recommended for all people at risk for stroke, but they are intriguing. These three drugs are commonly prescribed and well-tolerated, and could potentially have a protective effect on the brain after a stroke.�

At the time of discharge from the hospital, 65 percent of the people who had been taking the triple therapy showed neurological improvement from the time they were admitted. This was compared to 45 percent of those taking aspirin plus blood pressure drugs, 43 percent of those taking aspirin plus cholesterol drugs, 38 percent of those taking aspirin alone, and 33 percent of those taking none of the drugs.

Those taking all three drugs stayed in the hospital for an average of six days, compared to seven days for those taking aspirin only and nine days for those taking none of the drugs.

Those taking all three drugs were also more likely to be classified as having no or slight disability upon leaving the hospital: 35 percent, compared to 17 percent of those taking aspirin and blood pressure drugs, 14 percent of those taking aspirin and cholesterol drugs, 11 percent of those taking aspirin alone, and 10 percent of those taking none of the drugs.
 

- April 25, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology
 

www.aan.com

 
Subscribe to Stroke Newsletter
E-mail Address:

 

The study was supported in part by grants from the Harvard Center for Neurodegeneration and Repair, the Doris Duke Charitable Foundation, and the National Institute of Neurological Disorders and Stroke.

The American Academy of Neurology, an association of more than 19,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, autism and multiple sclerosis.

For more information about the American Academy of Neurology, visit www.aan.com.


Related Stroke News

New Effort to Treat Stroke More Effectively
REGARDS Study: Stroke Symptoms Common Among General Population
Video game for stroke rehabilitation?
Internal body clock dictates timing of different types of stroke
Stroke Costs in US set to top $2 trillion dollars
Agratroban May Promote Opening Of Arteries Following Stroke
SPARCL Trial: Atorvastatin reduces recurrent stroke risk
Healthy Lifestyle Reduces Women's Stroke Risk
Wingspan Intra-Cranial Stent, Alternative to Brain Surgery?
Blood pressure variability increases risk for stroke death


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us